Compound Detail
CHEMBL1255891
NARLAPREVIR 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
CCCC[C@H](NC(=O)[C@@H]1[C@@H]2[C@H](CN1C(=O)[C@@H](NC(=O)NC1(CS(=O)(=O)C(C)(C)C)CCCCC1)C(C)(C)C)C2(C)C)C(=O)C(=O)NC1CC1
Basic Information
| ChEMBL ID | CHEMBL1255891 |
| Name | NARLAPREVIR |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | RICZEKWVNZFTNZ-LFGITCQGSA-N |
5
Targets
14
Activities
3
Assay Types
0
PK Parameters
15
Publications
3
Known Names
4
Indications
1
Mechanisms
Molecular Properties
708.0
MW (Da)
3.62
ALogP
7
HBA
4
HBD
170.8
PSA (Ų)
0.21
QED
1
Ro5 Violations
13
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Hepatitis C virus serine protease, NS3/NS4A inhibitor | INHIBITOR | Hepatitis C virus serine protease, NS3/NS4A | ✓ | ✓ |
Indications
Hepatitis C Virus Diseases Hepatitis C, Chronic Liver Diseases
ATC Classification
J05AP14
narlaprevir
Level 1: ANTIINFECTIVES FOR SYSTEMIC USE
Level 2: ANTIVIRALS FOR SYSTEMIC USE
Activity Summary
Ki 6 meas. best 9.15
EC50 4 meas. best 7.4
IC50 4 meas. best 5.66
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | Ki | 9.15 | 8.51 | 0.7 | 4 |
| Hepatitis C virus serine protease, NS3/NS4A CHEMBL2095231 | Ki | 8.22 | 8.22 | 6.0 | 1 |
| Hepatitis C virus CHEMBL379 | Ki | 8.15 | 8.15 | 7.0 | 1 |
| Hepatitis C virus CHEMBL379 | EC50 | 7.4 | 7.4 | 40.0 | 1 |
| Replicase polyprotein 1ab CHEMBL4523582 | IC50 | 5.66 | 5.345 | 2200.0 | 4 |
| SARS-CoV-2 CHEMBL4303835 | EC50 | 5.11 | 5.0133 | 7700.0 | 3 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 20308381 | 10.1128/aac.00135-10 | Hepatitis C virus | 28 |
| 20308381 | 10.1128/aac.00135-10 | Unchecked | 3 |
| 37659195 | 10.1016/j.ejmech.2023.115772 | SARS-CoV-2 | 3 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 33191083 | 10.1016/j.bmc.2020.115860 | Replicase polyprotein 1ab | 2 |
| 20308381 | 10.1128/aac.00135-10 | ADMET | 1 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 1 |
| - | 10.1101/2020.04.21.054387 | SARS-CoV-2 | 1 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 1 |
| 30639895 | 10.1016/j.ejmech.2018.12.045 | Hepatitis C virus serine protease, NS3/NS4A | 1 |
| 30639895 | 10.1016/j.ejmech.2018.12.045 | Hepatitis C virus | 1 |
| 38365209 | 10.1021/acs.jmedchem.3c02248 | Replicase polyprotein 1ab | 1 |
| 37659195 | 10.1016/j.ejmech.2023.115772 | Replicase polyprotein 1ab | 1 |
| 37922830 | 10.1016/j.ejmech.2023.115919 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine